STAAR Surgical Company today reported that the U.S. Food and Drug Administration (FDA) has approved the Company’s Myopic VISIAN ICL for use in the correction of myopia in adults.
Original post by Glenn Hagele - USAEyes - glenn.hagele@usaeyes.org